LONDON, Dec 8 (Reuters) – The Magnum Ice Cream Company listed on Monday with a valuation of some 7.8 billion euros ($9.1 billion), below analyst expectations, with some investors unsure its sugar-heavy product can succeed as consumers grow more health-conscious.
Sign up here.
“The sentiment is that people are focusing on healthier lifestyles,” Jack Martin, investment director at Unilever shareholder Oberon Investments, told Reuters.
“There are regulatory headwinds against unhealthy foods because of the burden it places on healthcare systems, and GLP-1s are a potential headwind.”
SEPARATION COSTS, LACK OF DIVIDEND IN 2026 HIT MAGNUM STOCK
Magnum’s stock recovered slightly from a sluggish opening to settle just above the reference price set on Friday, which valued the company at roughly eight times its expected 2025 adjusted EBITDA, according to research firm Morningstar.
Ahead of the publication of Magnum’s prospectus, Barclays analysts predicted it would fetch an equity value of 10.1 billion to 10.8 billion euros and a share price above 20 euros per share.
Limited demand may have impacted the reference price, investment bank Degroof Petercam said in a note, while substantial separation costs from Unilever and the fact there will be no dividend in 2026 could be adding short-term pressure.
Degroof Petercam calculated that Magnum’s EV/EBITDA ratio – a key valuation metric – of 8x implied a 41% discount to peers including Nestle, Hershey and Mondelez, which trade at an average of 13.6x.
“I think that with setting the reference price low, they made the stock attractive for new investors,” said Fernand de Boer of Degroof Petercam, adding this had probably helped avoid a share price fall on the debut.
Item 1 of 3 Solero ice creams on the production line at Unilever Wall’s ice cream factory in Gloucester, Britain, November 21, 2025. REUTERS/Isabel Infantes/File Photo

MANAGEMENT HAS ‘WORK TO DO’ AS CEO PROMISES MORE AGILITY
Unilever is shedding a business unit whose cold supply chain demands more complex operations than its other food brands and personal care products like Dove soap and Axe deodorant.
Magnum CEO Peter ter Kulve, who wielded a replica Magnum ice cream the size of a tennis racquet at Monday’s bell-ringing ceremony, said the company would be “more agile, more focused, and more ambitious than ever” as an independent listed company.
There is hope that Magnum, with a strong brand and market position, can perform better outside Unilever, said Chris Beckett, consumer staples analyst at Quilter Cheviot, although a sugar-heavy product that is often weather-dependent for sales meant a more volatile mix than some peers.
“There will be some natural selling before we see a more stable shareholder base, as everyone who now owns Magnum shares had no choice in the matter as existing Unilever holders,” said Beckett.
“For now, it is a bit of a ‘show me’ story, and the management team will have some work to do.”
Investors automatically received one Magnum share for every five Unilever shares they hold. Magnum had warned its stock may face early downward pressure, with its shares not immediately eligible for inclusion in major indices such as the FTSE.
Shares in Unilever, which is retaining a 19.9% stake in the business but plans to exit within five years, edged down 0.5%.
Ben & Jerry’s annual revenue of 1.1 billion euros accounts for almost 14% of Magnum’s global turnover, compared to just 1.8% of Unilever.
($1 = 0.8584 euros)
Reporting by Alexander Marrow and Dimitri Rhodes; Editing by Bernadette Baum and Joe Bavier
Our Standards: The Thomson Reuters Trust Principles.


Leave a Reply